The LeForte System includes orthopedic implants used in craniomaxillofacial procedures, such as trauma and reconstruction. Bacterin plans a beta-launch of the LeForte System in the United States and Canada next month with the full product release to occur during the second quarter of 2012.
As a result of the agreement, the company has promoted Nick Navarro to executive vice president of medical devices. Mr. Navarro has previous experience with Johnson & Johnson.
Related Articles on Orthopedic Devices:
Global Orthopedic Implant Market to Reach $46.5B by 2017
InVivo Therapeutics Reports $3M Net Income in 3Q
Alphatec Spine Names Frances Harrison to Vice President Position
